Navigation Links
Disease Control App for Doctors Wins Health 2.0 Data Challenge, Analyze This!
Date:3/22/2011

SAN FRANCISCO, March 22, 2011 /PRNewswire/ -- Practice Fusion has named Epicenter the winner of Analyze This! part of Health 2.0's Spring Developer Challenge. Using Practice Fusion's sample of 15,000 de-identified health records, available free through Microsoft's Windows Azure Marketplace, Epicenter developer and self-confessed "data nerd," John Schrom, said his application could help identify and better control the spread of disease across America.

(Logo: http://photos.prnewswire.com/prnh/20091118/PFLOGO)

"Epicenter allows doctors to benchmark local patient data against a uniform dataset to identify anomalies in real-time," said Schrom. "It would also allow doctors to quickly identify local disease outbreaks, the groups they're occurring in, and then share those high-risk patient profiles with the wider medical community to drive proactive treatment initiatives, more targeted screening and faster warnings." A video demonstration of Schrom's Epicenter application can be viewed here.

As part of the Health 2.0 and US Department of Health and Human Services' (HHS) Developer Challenge, Analyze This! entrants were asked to use Practice Fusion's dataset to answer pressing public health questions around obesity trends, drug efficacy, disease outbreaks and treatment outcomes.

Schrom, a 26 year old epidemiologist with Hennepin County Medical Center in Minneapolis, believes increased access to de-identified patient data is critical to the development of potentially lifesaving healthcare informatics tools, like Epicenter.

"De-identified patient data is the best way to find health trends that would be missed otherwise – a broad view of what's happening on a national scale provides small practices ways to find out how their patient data matches up against national health quality measures and allows doctors to identify and mitigate risk better and faster," said Schrom.

The Windows Azure Marketplace dataset provided by Practice Fusion's Research Division for the Analyze This! contest included data on vitals, diagnoses, medications, prescriptions, immunizations and allergies in a de-identified, HIPAA-compliant format. Matthew Douglass, Practice Fusion's Vice President of Product Development, said applications like Epicenter illustrate the scope of possibility for data-driven health applications in the medical field.

"Researchers, developers and universities all need access to de-identified medical data to help inform studies, identify health trends and ultimately improve the standard of care for patients everywhere," said Douglass. "Analyze This! winner, Epicenter, shows us that a health dataset, such as Practice Fusion's, has a profound real-world use; enabling doctors in everyday clinics to analyze and better understand their own patient data for actionable insights."

Schrom receives $5,000 for his winning entry, as well as a ticket to Health 2.0 San Diego, where he'll deliver a live demo of the application on stage. Other finalists in the Health 2.0 Analyze This! competition included:

  • ScriptDrift: a web application used to analyze and interpret prescription data, including the relationships between medications, medical conditions, doses, doctors, patients, and how these factors intersect.
  • Red Corner: an interactive, color coded, 3D visualization of patient population health, including blood pressure, height, temperature, BMI, and other vital signs.
  • QuaMe (Quantified.Me): an iPad application that visualizes a user's personal health data (e.g., age, gender, BMI, chronic conditions) against the entire population to deliver peer group comparisons.

Practice Fusion's de-identified health dataset is a powerful resource available to the health sector for developing the latest treatments, medicines and care processes. More than 70,000 doctors and nine million patients make up Practice Fusion's health community, representing one of the largest and most comprehensive views of America's health in aggregate. Supported by Government health initiatives including Health.data.gov, Practice Fusion and Microsoft, through the Windows Azure Marketplace, are focused on delivering increased open access to broad-scale health data.

About Practice Fusion's Research Division

Practice Fusion's Research Division provides information from one of the largest, longitudinal clinical databases in the US for the purposes of clinical research and public health analysis. With a focus on real-time insight into adverse drug reactions, disease outbreaks and other national health issues, Practice Fusion's Research Division powers studies that are providing new insight into healthcare and how it is delivered.

Press Contact
Lilly Hanscom
San Francisco: 415.992.5439
Lhanscom@practicefusion.com

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Matt Douglass

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=93797


'/>"/>
SOURCE Practice Fusion
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
2. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
3. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
4. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
5. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
6. Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
7. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
8. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
9. Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
10. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
11. Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Biology News(10 mins):